Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles

INTRODUCTION: Triple-negative breast cancers (TNBCs) are characterised by lack of expression of hormone receptors and epidermal growth factor receptor 2 (HER-2). As they frequently express epidermal growth factor receptors (EGFRs), anti-EGFR therapies are currently assessed for this breast cancer su...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Jacot, William, Lopez-Crapez, Evelyne, Thezenas, Simon, Senal, Romain, Fina, Frédéric, Bibeau, Frédéric, Romieu, Gilles, Lamy, Pierre-Jean
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2011
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3326575/
https://ncbi.nlm.nih.gov/pubmed/22192147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3079
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak